Company: GEHC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001932393-25-000049
Chunk: 37

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 1
Chunk 37
---
 — — 22 — Interest rate swaps(2)— — — 80 — Debt basis adjustment on Long-term borrowings— — — (88)— Effects of fair value hedges— — — (8)— Foreign currency forward contracts59 16 — — (1)Other derivatives(3)— — 1 — (9)Effects of derivatives not designated as hedging instruments59 16 1 — (10)For the six months ended June 30, 2024Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$— $— $— $— $— Effects of cash flow hedges— — — — — Cross-currency swaps— — — 17 — Foreign currency forward and option contracts— — — 4 — Effects of net investment hedges(1)— — — 21 — Interest rate swaps(2)— — — (66)— Debt basis adjustment on Long-term borrowings— — — 52 — Effects of fair value hedges— — — (13)— Foreign currency forward contracts(7)(2)— — — Other derivatives(3)— — 5 — 23 Effects of derivatives not designated as hedging instruments(7)(2)5 — 23 (1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three and six months ended June 30, 2025 and 2024.(2) Amount includes interest expense on interest rate derivatives of $(4) million and $(7) million for the three months ended June 30, 2025 and 2024, respectively, and $(8) million and $(13) million for the six months ended June 30, 2025 and 2024, respectively.(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.(4) Amounts are inclusive of gains (losses) in Other (income) expense – net in the Condensed Consolidated Statements of Income.FAIR VALUE MEASUREMENTS.The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.Fair Value of Assets and Liabilities Me